Copyright Reports & Markets. All rights reserved.

Global and United States Retinal Drugs and Biologics Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Retinal Drugs and Biologics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Retinal Drugs and Biologics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Type
    • 1.4.2 Age Related Macular Degeneration
    • 1.4.3 Diabetic Retinopathy
    • 1.4.4 Ocular Inflammatory Disease (Uveitis)
    • 1.4.5 Macular Hole
  • 1.5 Market by Application
    • 1.5.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Retinal Drugs and Biologics Market Size, Estimates and Forecasts
    • 2.1.1 Global Retinal Drugs and Biologics Revenue 2015-2026
    • 2.1.2 Global Retinal Drugs and Biologics Sales 2015-2026
  • 2.2 Global Retinal Drugs and Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Retinal Drugs and Biologics Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Retinal Drugs and Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Retinal Drugs and Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Retinal Drugs and Biologics Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Retinal Drugs and Biologics Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Retinal Drugs and Biologics Revenue Forecast by Region (2021-2026)

3 Global Retinal Drugs and Biologics Competitor Landscape by Players

  • 3.1 Global Top Retinal Drugs and Biologics Sales by Manufacturers
    • 3.1.1 Global Retinal Drugs and Biologics Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Retinal Drugs and Biologics Manufacturers by Revenue
    • 3.2.1 Global Retinal Drugs and Biologics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Retinal Drugs and Biologics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Retinal Drugs and Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Retinal Drugs and Biologics Revenue in 2019
    • 3.2.5 Global Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Retinal Drugs and Biologics Price by Manufacturers
  • 3.4 Global Retinal Drugs and Biologics Manufacturing Base Distribution, Product Types
    • 3.4.1 Retinal Drugs and Biologics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Retinal Drugs and Biologics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Retinal Drugs and Biologics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Retinal Drugs and Biologics Market Size by Type (2015-2020)
    • 4.1.1 Global Retinal Drugs and Biologics Sales by Type (2015-2020)
    • 4.1.2 Global Retinal Drugs and Biologics Revenue by Type (2015-2020)
    • 4.1.3 Retinal Drugs and Biologics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Retinal Drugs and Biologics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Retinal Drugs and Biologics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Retinal Drugs and Biologics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Retinal Drugs and Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Retinal Drugs and Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Retinal Drugs and Biologics Market Size by Application (2015-2020)
    • 5.1.1 Global Retinal Drugs and Biologics Sales by Application (2015-2020)
    • 5.1.2 Global Retinal Drugs and Biologics Revenue by Application (2015-2020)
    • 5.1.3 Retinal Drugs and Biologics Price by Application (2015-2020)
  • 5.2 Retinal Drugs and Biologics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Retinal Drugs and Biologics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Retinal Drugs and Biologics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Retinal Drugs and Biologics Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
    • 6.1.1 United States Retinal Drugs and Biologics Sales YoY Growth 2015-2026
    • 6.1.2 United States Retinal Drugs and Biologics Revenue YoY Growth 2015-2026
    • 6.1.3 United States Retinal Drugs and Biologics Market Share in Global Market 2015-2026
  • 6.2 United States Retinal Drugs and Biologics Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Retinal Drugs and Biologics Players by Sales (2015-2020)
    • 6.2.2 United States Top Retinal Drugs and Biologics Players by Revenue (2015-2020)
  • 6.3 United States Retinal Drugs and Biologics Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Retinal Drugs and Biologics Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Retinal Drugs and Biologics Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Retinal Drugs and Biologics Price by Type (2015-2020)
  • 6.4 United States Retinal Drugs and Biologics Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Retinal Drugs and Biologics Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Retinal Drugs and Biologics Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Retinal Drugs and Biologics Price Forecast by Type (2021-2026)
  • 6.5 United States Retinal Drugs and Biologics Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Retinal Drugs and Biologics Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Retinal Drugs and Biologics Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Retinal Drugs and Biologics Price by Application (2015-2020)
  • 6.6 United States Retinal Drugs and Biologics Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Retinal Drugs and Biologics Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Retinal Drugs and Biologics Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Retinal Drugs and Biologics Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
  • 7.2 North America Retinal Drugs and Biologics Market Facts & Figures by Country
    • 7.2.1 North America Retinal Drugs and Biologics Sales by Country (2015-2020)
    • 7.2.2 North America Retinal Drugs and Biologics Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
  • 8.2 Europe Retinal Drugs and Biologics Market Facts & Figures by Country
    • 8.2.1 Europe Retinal Drugs and Biologics Sales by Country
    • 8.2.2 Europe Retinal Drugs and Biologics Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Retinal Drugs and Biologics Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Retinal Drugs and Biologics Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Retinal Drugs and Biologics Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
  • 10.2 Latin America Retinal Drugs and Biologics Market Facts & Figures by Country
    • 10.2.1 Latin America Retinal Drugs and Biologics Sales by Country
    • 10.2.2 Latin America Retinal Drugs and Biologics Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Retinal Drugs and Biologics Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Retinal Drugs and Biologics Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Retinal Drugs and Biologics Sales by Country
    • 11.2.2 Middle East and Africa Retinal Drugs and Biologics Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 ALLERGAN
    • 12.1.1 ALLERGAN Corporation Information
    • 12.1.2 ALLERGAN Description and Business Overview
    • 12.1.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
    • 12.1.5 ALLERGAN Recent Development
  • 12.2 AbbVie
    • 12.2.1 AbbVie Corporation Information
    • 12.2.2 AbbVie Description and Business Overview
    • 12.2.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 AbbVie Retinal Drugs and Biologics Products Offered
    • 12.2.5 AbbVie Recent Development
  • 12.3 Alimera Sciences
    • 12.3.1 Alimera Sciences Corporation Information
    • 12.3.2 Alimera Sciences Description and Business Overview
    • 12.3.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Alimera Sciences Retinal Drugs and Biologics Products Offered
    • 12.3.5 Alimera Sciences Recent Development
  • 12.4 Janssen Biotech
    • 12.4.1 Janssen Biotech Corporation Information
    • 12.4.2 Janssen Biotech Description and Business Overview
    • 12.4.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Janssen Biotech Retinal Drugs and Biologics Products Offered
    • 12.4.5 Janssen Biotech Recent Development
  • 12.5 Swedish Orphan Biovitrum
    • 12.5.1 Swedish Orphan Biovitrum Corporation Information
    • 12.5.2 Swedish Orphan Biovitrum Description and Business Overview
    • 12.5.3 Swedish Orphan Biovitrum Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Products Offered
    • 12.5.5 Swedish Orphan Biovitrum Recent Development
  • 12.6 Roche
    • 12.6.1 Roche Corporation Information
    • 12.6.2 Roche Description and Business Overview
    • 12.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Roche Retinal Drugs and Biologics Products Offered
    • 12.6.5 Roche Recent Development
  • 12.7 Bristol-Myers Squibb
    • 12.7.1 Bristol-Myers Squibb Corporation Information
    • 12.7.2 Bristol-Myers Squibb Description and Business Overview
    • 12.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Products Offered
    • 12.7.5 Bristol-Myers Squibb Recent Development
  • 12.8 Genzyme
    • 12.8.1 Genzyme Corporation Information
    • 12.8.2 Genzyme Description and Business Overview
    • 12.8.3 Genzyme Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Genzyme Retinal Drugs and Biologics Products Offered
    • 12.8.5 Genzyme Recent Development
  • 12.9 Genentech
    • 12.9.1 Genentech Corporation Information
    • 12.9.2 Genentech Description and Business Overview
    • 12.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Genentech Retinal Drugs and Biologics Products Offered
    • 12.9.5 Genentech Recent Development
  • 12.10 OCULAR THERAPEUTIX
    • 12.10.1 OCULAR THERAPEUTIX Corporation Information
    • 12.10.2 OCULAR THERAPEUTIX Description and Business Overview
    • 12.10.3 OCULAR THERAPEUTIX Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Products Offered
    • 12.10.5 OCULAR THERAPEUTIX Recent Development
  • 12.11 ALLERGAN
    • 12.11.1 ALLERGAN Corporation Information
    • 12.11.2 ALLERGAN Description and Business Overview
    • 12.11.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 ALLERGAN Retinal Drugs and Biologics Products Offered
    • 12.11.5 ALLERGAN Recent Development
  • 12.12 UCBCares
    • 12.12.1 UCBCares Corporation Information
    • 12.12.2 UCBCares Description and Business Overview
    • 12.12.3 UCBCares Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 UCBCares Products Offered
    • 12.12.5 UCBCares Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Retinal Drugs and Biologics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Retinal Drugs and Biologics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Retinal Drugs and Biologics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Drugs and Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Retinal Drugs and Biologics market is segmented into
    Age Related Macular Degeneration
    Diabetic Retinopathy
    Ocular Inflammatory Disease (Uveitis)
    Macular Hole

    Segment by Application, the Retinal Drugs and Biologics market is segmented into
    Hospitals
    Clinics
    Others

    Regional and Country-level Analysis
    The Retinal Drugs and Biologics market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Retinal Drugs and Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Retinal Drugs and Biologics Market Share Analysis
    Retinal Drugs and Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Retinal Drugs and Biologics business, the date to enter into the Retinal Drugs and Biologics market, Retinal Drugs and Biologics product introduction, recent developments, etc.
    The major vendors covered:
    ALLERGAN
    AbbVie
    Alimera Sciences
    Janssen Biotech
    Swedish Orphan Biovitrum
    Roche
    Bristol-Myers Squibb
    Genzyme
    Genentech
    OCULAR THERAPEUTIX
    Bausch & Lomb
    UCBCares

    Buy now